GoldState Music | $500,000,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
Certified by Founder
Lodge
Crossbow Therapeutics, Inc
start up
United States
- Cambridge, MA
- 12/07/2023
- Series A
- $80,000,000
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.
- Industry Biotechnology Research
- Website https://www.crossbowtx.com/
- LinkedIn https://www.linkedin.com/company/crossbow-therapeutics-inc/
Brellium | $13,700,000 | (Apr 22, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Cosmic Robotics | $4,000,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)
Kenzo Security | $45,000,000 | (Apr 22, 2025)
Electra.aero | $115,000,000 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
Booked it | $3,316,375 | (Apr 18, 2025)
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)